Efficacy and safety of belimumab for the treatment of refractory childhood-onset systemic lupus erythematosus: A single-center, real-world, retrospective study

OBJECTIVE: This study aimed to investigate the efficacy and safety of belimumab for treating children with refractory childhood-onset systemic lupus erythematosus (cSLE). METHODS: Twenty-six cSLE patients who received belimumab treatment in our hospital from January 2020 to September 2021 (23 of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Dahai, Shan, Chunrong, Liu, Jia, Zhang, Ranran, Zhu, Guohao, Gao, Tingting, Chang, Hong, Gao, Shan, Bai, Cui, Nie, Nana, Zhang, Qiuye, Lin, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794867/
https://www.ncbi.nlm.nih.gov/pubmed/36591249
http://dx.doi.org/10.3389/fimmu.2022.1067721

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794867/
https://www.ncbi.nlm.nih.gov/pubmed/36591249
http://dx.doi.org/10.3389/fimmu.2022.1067721

Ejemplares similares